To recover your password please fill in your email address
Please fill in below form to create an account with us
Phase II trial of panitumumab, cisplatin and gemcitabine in bIliary tract cancer.
|
Trial Summary: |
Phase II trial to evaluate the potential molecular profile of biliary tract cancer and the clinical benefit and safety of panitumumab, cisplatin and gemcitabine in the treatment of biliary tract cancer. |
|
Supported By: |
Cancer Australia; Amgen; NHMRC CTC; AGITG |
|
Eligibility: |
Patients with inoperable biliary tract cancer and a K-RAS wild-type oncogene status. |
|
Registration ID: |
ACTRN12611000245998 |
|
Participation: |
Australia |
|
Australian Lead Group: |
AGITG |
|
Status: |
closed |
|
Activation Date: |
21/06/2012 |
|
Chairs: |
Jenny Shannon |
|
Contact: |